Skip to main content

Brooklyn ImmunoTherapeutics, Inc. - Common Stock (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist

Other Filings

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Form 424B5
Source: SEC/Edgar
March 25, 2014
Form 8-K
Source: SEC/Edgar
March 24, 2014
Form 8-K
Source: SEC/Edgar
March 17, 2014
Form D
Source: SEC/Edgar
March 06, 2014
Form 8-K
Source: SEC/Edgar
March 04, 2014
Form 8-K
Source: SEC/Edgar
March 04, 2014
Form 8-K
Source: SEC/Edgar
March 02, 2014
Form 8-K
Source: SEC/Edgar
February 17, 2014
Form EFFECT
Source: SEC/Edgar
February 05, 2014
Form 8-K
Source: SEC/Edgar
January 26, 2014
Form 8-K
Source: SEC/Edgar
January 16, 2014
Form 8-K
Source: SEC/Edgar
January 12, 2014
Form 8-K
Source: SEC/Edgar
January 01, 2014
Form SC 13D/A
Source: SEC/Edgar
December 30, 2013
Form 8-K
Source: SEC/Edgar
December 22, 2013
Form 8-K
Source: SEC/Edgar
December 19, 2013
Form CT ORDER
Source: SEC/Edgar
December 18, 2013
Form POS AM
Source: SEC/Edgar
December 16, 2013
Form 8-K
Source: SEC/Edgar
December 05, 2013
Form 8-K
Source: SEC/Edgar
December 03, 2013
Form 8-K
Source: SEC/Edgar
December 01, 2013
Form 8-K
Source: SEC/Edgar
November 24, 2013
Form S-8
Source: SEC/Edgar
November 24, 2013
Form 8-K
Source: SEC/Edgar
November 11, 2013
Form 8-K
Source: SEC/Edgar
October 31, 2013
Form 8-K
Source: SEC/Edgar
October 27, 2013
Form 8-K
Source: SEC/Edgar
October 27, 2013
Form 8-K
Source: SEC/Edgar
October 27, 2013
Form 8-K
Source: SEC/Edgar
October 14, 2013
Form 8-K
Source: SEC/Edgar
October 10, 2013
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.